The lack of insider transactions in the last three months an...
The lack of insider transactions in the last three months and low insider ownership in Sutro Biopharma is concerning. Investors should also note the company's 3 warning signs.
Sutro Biopharma Falls To US$3.55, But Insiders Sold At Lower Price
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3239Followers
0Following
8005Visitors
Follow